Title: Faria C, et al. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis. Am Health Drug Benefits. 2014 Jan;7(1):50-8.
115956-12-2
127951-99-9
105826-92-4
89565-68-4
833482-77-2
116-25-6 | 1-Hydroxymethyl-5,5-dimethylhydantoin | AA000HCO | MFCD00020866
119061-16-4 | 2-(4-Chlorophenoxy)pentanoic acid | AA000I1S | MFCD02295839
119223-01-7 | 5-(Chloromethyl)-3-cyclopropyl-1,2,4-oxadiazole | AA000IC0 | MFCD09816101
1194-86-1 | (R)-3-Thienylglycine | AA000IMN | MFCD00079614
119584-72-4 | 2-(Ethylamino)-6-fluorobenzonitrile | AA000IWZ | MFCD12193244
1227581-80-7 | 2-Nitro-6-(trifluoromethyl)benzonitrile | AA000JA3 | MFCD16606330
122855-37-2 | Ethyl 8-hydroxyquinoline-3-carboxylate | AA000JIV | MFCD18416648
122965-43-9 | Methylene Blue hydrate | AA000JRY | MFCD00012111
1232039-16-5 | 6-Methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridin-2-amine | AA000K31 | MFCD18711537
123387-49-5 | tert-Butyl 4-phenylpiperidine-1-carboxylate | AA000KE4 | MFCD09953385